On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...

We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...

Understanding food labels enables consumers to make more informed decisions about their emulsifier intake. Manufacturers must list these additives in ingredient statements, though they may appear ...

MANILA, Philippines — The country’s sales of private label products in the food and beverage sector are expected to hit to nearly $900 million this year, driven by Filipinos’ growing demand ...

THURSDAY, Jan. 23, 2025 (HealthDay News) -- It's easy these days to see how many calories a cheeseburger will set you back, or how many added sugars are in a jar of pasta sauce. But nutrition ...

After 20 years of hemming, hawing, and “evaluating the science,” the FDA is finally muscling its way onto the most coveted ...

The packaging on dog food can sure be overwhelming, especially with all those claims, percentages, and unpronounceable ingredients. Understandably, you want the best for your dog, but how do you ...

Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA CAMBRIDGE, Mass., Jan. 2 ...

Understanding food labels becomes essential for managing cholesterol intake. Pay particular attention to serving sizes, saturated fat content, and the presence of trans fats when making food choices.

Violations of Pregnant Women’s Rights Amid Israel’s Assault on Gaza,” finds that Israeli forces’ unlawful blockade of the ...

A new study finds calorie labels make a small but potentially significant impact on food selection and calorie intake. A new study finds they make a small but potentially meaningful difference in our ...

Despite long covid's vast reach, the federal government's investment in researching the disease — to the tune of $1.15 billion as of December — has so far failed to bring any new treatments to market.